Northern Trust’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Northern Trust’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-234,475	Closed	-$1.15M	–	4494
2024 Q1	$1.15M	Buy	234,475 +9,629	+4%	+$45.7K	﹤0.01%	3251
2023 Q4	$821K	Buy	224,846 +3,379	+2%	+$9.26K	﹤0.01%	3379
2023 Q3	$492K	Buy	221,467 +2,416	+1%	+$6.75K	﹤0.01%	3525
2023 Q2	$745K	Buy	219,051 +30,054	+16%	+$108K	﹤0.01%	3445
2023 Q1	$754K	Buy	188,997 +5,790	+3%	+$25.5K	﹤0.01%	3311
2022 Q4	$997K	Sell	183,207 -409	-0.2%	-$2.41K	﹤0.01%	3257
2022 Q3	$923K	Buy	183,616 +9,487	+5%	+$46.7K	﹤0.01%	3328
2022 Q2	$664K	Buy	+174,129	New	+$1.11M	﹤0.01%	3456

Northern Trust's TGAN Position: Q2 2024 in Review

Northern Trust sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 234,475 shares — an estimated $1.15M sold.

Northern Trust first reported a position in TGAN in Q2 2022 and held it in 8 quarters. The position peaked at $1.15M in Q1 2024. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

Northern Trust reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Northern Trust sold 234,475 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $1.15M.
Northern Trust first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
Northern Trust's Transphorm, Inc. Common Stock position peaked at $1.15M in Q1 2024.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Northern Trust's 13F filing for Q2 2024, filed 14 Aug 2024.